Table 4 Univariate analyses of risk factors for overall 30-day mortality
Variable | Deaths (n = 18) | Survivors (n = 31) | Odds ratio (95%CI) | p |
|---|---|---|---|---|
n (%) | n (%) | |||
Male sex | 10 (56) | 19 (61) | 0.79 (0.24 – 2.56) | 0.69 |
Age (each 10 years) | 10 (56) | 12 (39) | 0.97 (0.68 – 1.38) | 0.85 |
Liver transplant | 15 (83) | 10 (32) | 10.5 (2.46 – 44.8) | 0.001 |
Infection acquired in the ICU | 16 (89) | 8 (26) | 12.2 (2.83 – 52.7) | 0.001 |
Previous use of any antibiotic a | 6 (40) | 16 (64) | 0.38 (0.10 – 1.40) | 0.14 |
Previous use of carbapenem a | 5 (33) | 6 (24) | 1.58 (0.39 – 6.50) | 0.52 |
Extra-urinary site of infection | 17 (94) | 18 (58) | 12.4 (1.45 – 100.0) | 0.02 |
Primary bacteremia | 7 (39) | 10 (32) | ||
Pneumonia | 8 (44) | 5 (16) | ||
Surgical site infection | 2 (11) | 3 (10) | ||
Bacteremia b | 12 (67) | 16 (52) | 1.65 (0.49 – 5.52) | 0.42 |
Central venous catheter | 17 (94) | 14 (45) | 20.6 (2.44 – 175.0) | 0.005 |
Mechanical ventilation | 15 (83) | 10 (32) | 10.5 (2.46 – 44.8) | 0.001 |
Serum creatinine (for each 100 μmol/L) c | 200 (100 – 250) | 220 (110 – 460) | 0.76 (0.52 – 1.11) d | 0.16 |
Hemodialysis | 7 (39) | 5 (17) | 3.31 (0.86 – 12.7) | 0.08 |
Therapy for acute rejection | 2 (11) | 10 (32) | 0.28 (0.07 – 1.16) | 0.08 |
Septic shock | 10 (56) | 5 (16) | 4.17 (1.15 – 15.0) | 0.03 |
Appropriate empiric therapy | 11 (50) | 18 (58) | 0.79 (0.24 -2.56) | 0.69 |
Resistance to carbapenem | 9 (50) | 9 (29) | 2.44 (0.73 – 8.17) | 0.15 |